Thomas G. Ricks, Director at Sensei Biotherapeutics, Inc. (SNSE), bought 40,000 shares at $5.86 ($250K) on 2021-12-10, disclosed to the SEC on 2021-12-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.62 | 20,000 | $132K | 53.0% |
| 2 | $5.86 | 20,000 | $117K | 47.0% |
| Total | $6.24 avg | 40,000 | $250K | 100% |
| Filing → |
| OVV | SELL | 2022-04-19 | $537K | — | Filing → |
| OVV | BUY | 2020-03-18 | $108K | — | Filing → |
| OVV | BUY | 2020-03-10 | $305K | — | Filing → |